Literature DB >> 20515818

Roles of protein kinase B/Akt in lung cancer.

Cheng-Xiong Xu1, Hua Jin, Ji-Young Shin, Ji-Eun Kim, Myung-Haing Cho.   

Abstract

Lung cancer is the leading cause of cancer-related death worldwide and has frequently been associated with over-activated protein kinase B (PKB)/Akt. Akt is a serine/threonine protein kinase that plays an important role in cell growth, proliferation, and survival. Many lines of evidence point to the contribution of deregulated Akt in development or progression of lung cancer. In addition, recent studies have demonstrated that cancer cells defend themselves from therapeutic treatment through activation of pro-survival signals, including the Akt pathway. In this review, we described the way in which the Akt pathway is activated in development and progression of lung cancer, and the way in which deregulated Akt plays a significant role in lung tumorigenesis and resistance to chemo- or radiotherapy. In this review, we also discussed the potential of the Akt pathway as a target of lung cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515818     DOI: 10.2741/e206

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  20 in total

1.  The novel miR-9500 regulates the proliferation and migration of human lung cancer cells by targeting Akt1.

Authors:  J K Yoo; H Y Jung; J M Lee; H Yi; S-H Oh; H Y Ko; H Yoo; H-R Kim; H Song; S Kim; J K Kim
Journal:  Cell Death Differ       Date:  2014-03-21       Impact factor: 15.828

2.  Molecular dissection of AKT activation in lung cancer cell lines.

Authors:  Yanan Guo; Jinyan Du; David J Kwiatkowski
Journal:  Mol Cancer Res       Date:  2013-01-14       Impact factor: 5.852

3.  Ellagic acid promotes A549 cell apoptosis via regulating the phosphoinositide 3-kinase/protein kinase B pathway.

Authors:  Qiong Liu; Xiaobing Liang; Chengwei Niu; Xuelan Wang
Journal:  Exp Ther Med       Date:  2018-05-18       Impact factor: 2.447

4.  Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase.

Authors:  Marianna Scrima; Carmela De Marco; Fernanda Fabiani; Renato Franco; Giuseppe Pirozzi; Gaetano Rocco; Maria Ravo; Alessandro Weisz; Pietro Zoppoli; Michele Ceccarelli; Gerardo Botti; Donatella Malanga; Giuseppe Viglietto
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

Review 5.  The role of mitochondria in the development and progression of lung cancer.

Authors:  Emily R Roberts; Kelly Jean Thomas
Journal:  Comput Struct Biotechnol J       Date:  2013-12-07       Impact factor: 7.271

6.  VAV3 oncogene expression in colorectal cancer: clinical aspects and functional characterization.

Authors:  Yih-Huei Uen; Chia-Lang Fang; You-Cheng Hseu; Pei-Chun Shen; Hsin-Ling Yang; Kuo-Shan Wen; Shih-Ting Hung; Lu-Hai Wang; Kai-Yuan Lin
Journal:  Sci Rep       Date:  2015-03-20       Impact factor: 4.379

7.  Inhibition of Nonsmall Cell Lung Cancer Cell Migration by Protein Arginine Methyltransferase 1-small Hairpin RNA Through Inhibiting Epithelial-mesenchymal Transition, Extracellular Matrix Degradation, and Src Phosphorylation In Vitro.

Authors:  Ting Zhang; Ge Cui; Yun-Liang Yao; Yue Guo; Qi-Chun Wang; Xi-Ning Li; Wen-Ming Feng
Journal:  Chin Med J (Engl)       Date:  2015-05-05       Impact factor: 2.628

8.  In silico and in vitro approaches to evaluate the bioactivity of Cassia auriculata L extracts.

Authors:  Rajagopal Anitha; Rajakannu Subashini; Ponnusamy Senthil Kumar
Journal:  IET Nanobiotechnol       Date:  2020-05       Impact factor: 1.847

9.  Aerosol delivery of beclin1 enhanced the anti-tumor effect of radiation in the lungs of K-rasLA1 mice.

Authors:  Ji-Young Shin; Hwang-Tae Lim; Arash Minai-Tehrani; Mi-Suk Noh; Ji-Eun Kim; Ji-Hye Kim; Hu-Lin Jiang; Rohidas Arote; Doo-Yeol Kim; Chanhee Chae; Kee-Ho Lee; Mi-Sook Kim; Myung-Haing Cho
Journal:  J Radiat Res       Date:  2012-06-06       Impact factor: 2.724

10.  Ganoderma tsugae Induces S Phase Arrest and Apoptosis in Doxorubicin-Resistant Lung Adenocarcinoma H23/0.3 Cells via Modulation of the PI3K/Akt Signaling Pathway.

Authors:  Yang-Hao Yu; Han-Peng Kuo; Hui-Hsia Hsieh; Jhy-Wei Li; Wu-Huei Hsu; Shih-Jung Chen; Muh-Hwan Su; Shwu-Huey Liu; Yung-Chi Cheng; Chih-Yi Chen; Ming-Ching Kao
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.